Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany
Influenza and Other Respiratory Viruses · 2026-06 · 20 (6)
DOI: 10.1111/irv.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 17.06.2026. Verfasst von Wei Cai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unit 36, Respiratory Infections, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, Antiviral Agents. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Robert Koch Institut, Bundesministerium für Gesundheit, European Centre for Disease Prevention and Control.
Abstract (Originalsprache)
After introducing nirsevimab during the 2024/2025 respiratory syncytial virus (RSV) season in Germany, RSV activity in infants under 1 year dropped by 50% in primary care and 50%–70% in secondary care. Inpatients under 6 months showed the greatest reduction. RSV severity decreased with fewer RSV‐associated ICU admissions and shorter hospital stays. RSV sequence analysis identified four known polymorphisms in the nirsevimab binding site among inpatients; none associated with resistance. These findings indicate that nirsevimab effectively reduced medically attended RSV disease in infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit 36, Respiratory Infections, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
- Unit 17, Influenza and Other Respiratory Viruses, Department of Infectious Diseases, National Influenza Centre, Robert Koch Institute, Berlin, Germany.
- Unit 17, Influenza and Other Respiratory Viruses, Department of Infectious Diseases, Consultant Laboratory for RSV, PIV and HMPV, Robert Koch Institute, Berlin, Germany.
- Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
- HELIOS KLINIKEN GmbH, Berlin, Germany.
ORCID-Profile: Wei Cai, Isabelle Maronde, Sophie Köndgen, Barbara Biere, Silke Buda, Brunhilde Schweiger, Doreen Staat, Thorsten Wolff, Ralf Dürrwald, Djin-Ye Oh, Kristin Tolksdorf, Janine Reiche
Förderung
- Robert Koch Institut
- Bundesministerium für Gesundheit
- European Centre for Disease Prevention and Control
- Vaccine effectiveness, burden and impact studies
Zitieren
APA
Cai, W., Maronde, I., Köndgen, S., Biere, B., Buda, S., Schweiger, B., Staat, D., Haas, W., Schuler, E., Virologic SARI Surveillance Study Group, Wolff, T., Dürrwald, R., Oh, D. Y., Tolksdorf, K., & Reiche, J. (2026). Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany. Influenza and Other Respiratory Viruses, 20(6). https://doi.org/10.1111/irv.70274
Vancouver
Cai W, Maronde I, Köndgen S, Biere B, Buda S, Schweiger B, et al. Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany. Influenza and Other Respiratory Viruses. 2026;20(6). doi:10.1111/irv.70274
BibTeX
@article{Cai2026,
author = {Cai, Wei and Maronde, Isabelle and Köndgen, Sophie and Biere, Barbara and Buda, Silke and Schweiger, Brunhilde and Staat, Doreen and Haas, Walter and Schuler, Ekkehard and Virologic SARI Surveillance Study Group, Virologic SARI Surveillance Study Group and Wolff, Thorsten and Dürrwald, Ralf and Oh, Djin-Ye and Tolksdorf, Kristin and Reiche, Janine},
title = {Reduction in Respiratory Syncytial Virus (RSV)‐Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany},
journal = {Influenza and Other Respiratory Viruses},
year = {2026},
volume = {20},
number = {6},
doi = {10.1111/irv.70274}
}
EUVIMED